Infezioni delle vie urinarie. Il ruolo delle piante medicinali nella prevenzione

Le infezioni delle vie urinarie (IVU) rappresentano una delle principali cause di infezioni in età pediatrica. Fino a non molti anni orsono, il trattamento preventivo raccomandato era costituito dalla profilassi antibiotica protratta per lunghi periodi. Il riscontro di una scarsa efficacia, insieme all’aumento del fenomeno dell’antibiotico resistenza, ha promosso la ricerca di altri possibili interventi preventivi. L’articolo di Domenico Careddu, pubblicato su Il Pediatra 3/2016, prende in considerazione, basandosi su criteri EBM, il ruolo delle piante medicinali.

Bibliografia

1. Urinary tract infection: clinical practice guidelines for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128-595.
2. National Institute for Health and Clinical Excellence (NICE). NICE clinical guideline.Urinary tract infection in children: diagnosis, treatment and long-term management. London 2007 (http://guidance.nice.org.uk/CGOSA).
3. Platt C, Larcombe J, Dudley J, et al. Implementation of NICE guidance on urinary tract infections in children in primary and secondary care. Acta Pediatr 2015 Jun; 104(6): 630-7.
4. Ammenti A, Cataldi L, Chimenez R, et al. Italian Society of Pediatric Nephrology. Febrile urinary tract infections in young children: reccommendations for diagnosis, treatment and follow up. Acta Paediatr 2012 May; 101(5): 451-7.
5. Montini G, Tullus K, Hewitt I.Febrile urinary tract infections in children. N Engl J Med 2011; 365 (3): 239-50.
6. Zaffanello M, Tardivo S, Cataldi L, et al. Genetic susceptibility to renal scar formation after urinary tract infection: a systematic review and meta-analysis of candidate gene polymorphisms. Pediatr Nephrol 2011; 26(7): 1017-29.
7. Williams GJ, Makaskill P, Chan SF, et al. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis 2010;10(4): 240-50.
8. Montini G, Zucchetta P, Tomasi L, et al. Value of imaging studies after a first febrile urinary tract infection in young children: data from italian renal infection study 1. Pediatrics 2009; 123(2)2239-46.
9. Shim YH, Lee JW, Lee SJ. The risk factors of recurrent urinary tract infection in infants with normal urinary systems. Pediatr Nephrol 2009; 24(2): 309-12.
10. Masnata G, Demelas F, Ponticelli A, et al. Outcome in children with recurrent urinary tract infections and LUTS managed with simple behavioural therapy. Urodinamica (Editrice Kurtis). 2007; 17(2): 101-2.
11. William G, Craig JC. Long.term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 2011; (3): CD001534.
12. Bryce A, Hay AD, Lane IF et al. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by E.coli and association with routine use of antibiotics in primary care: systematic review and mrta-analysis. BMJ 1016 Mar 15; 352: i939.
13. Hewitt IK, Zucchetta P, Rigon L, et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infectio Study Trials. Pediatrics 2008; 122(3): 486-90.
14. Super EA, Kemper KJ, Woods C, et al. Cranberry use among pediatric nephrology patients. Ambul Pediatr 2005; 5(4): 249-52.
15. Istituto Nazionale di Statistica. Le terapie non convenzionali in Italia (Indagine multiscopo sulle condizioni di salute e ricorso ai servizi sanitari 2013), ISTAT 2013.
16. Zuzak TJ, Bonkova J, Careddu D, et al. Use of complementary and alternative medicine by children in Europe: published data and expert perspectives. Complementary Therapies in Medicine 2012.
17. Murgia V, Careddu D. EBP Evidence Based Phytotherapy. Area Pediatrica 2010; 1 :26-31.
18. Wang CH, Fang CC, Chen NC, et al. Cranberry-containing products for prevention of urinary tract infections in suceptible population: a systemtic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172: 988-96.
19. Howell AB, Reed JD, Krueger CG, et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry.2005; 66: 2281-91.
20. Cote J, Caillet S, Dussault D, et al. Effect of juice processing on cranberry antibacterial properties. Food Res Int 2011;442922-29.
21. Grace MH, Massey AR, Mbeunkui F, et al. Comparison of health-relevant flavonoids in commonly consumed cranberry products. J Food Sci 2012; 77: H177-183.
22. Japson RG, William G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012; 10: CD001321.
23. Howell AB, Botto H, Combescure C, Blanc-Potard AB, et al. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010; 14: 10-94.
24. Pinzon-Arango PA, Liu Y, Camesano TA. Role of cranberry on bacterial adhesion forces and implications for Escherichia coli-uroepithelial cell attachment. J Med Food 2009 Apr; 12(2): 259-70.
25. Di Pierro F. Argomenti di fitoterapia biofarmaceutica 2014; CEC Editore.
26. Jepson RG, Graig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008; (1): CD001321.
27. Ferrara P, Romaniello L, Vitelli O, et al. Cranberry juice for the prevention of recurrent urinary tract infections: a randomized placebo-controlled trial in children. Scand J Urol Nephrol. 2009; 43: 369-73.
28. Salo j, Uhari M, Helminen M, et al. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trial. Clin Infect Dis. 2012; 54: 340-346.
29. Afshar K, Stothers L, Scott H, et al. Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol. 2012; 188 (4) suppl9: 1584-7.
30. Mutlu H, Ekinci Z. Urinary tract infection prophylaxis in children with neurogenic bladder with cranberry capsules: randomized controlled trial. ISRN Pediatr 2012; 2012: 317280.
31. Goj V, Bernardo L, Masnata G. Vesicoureteral reflux (VUR): the role of cranberry prophylaxis. Pediatr Nephrol 2010; 25: 1851.
32. Maringhini SS, Costa AA, Migliore VV, et al. Cranberry in children with recurrent urinary tract infections. Pediatr Nephrol 2010; 25: 1854.
33. Fanos V, Atzei A, Zaffanello M, Piras A, Cataldi L. Cranberry and prevention of urinary tract infections in children. J Chemother 2006; 3: 21-24.
34. Fernandez-Puentes V, Uberos J, Rodriguez-Belmonte R, et al. Efficacy and safety profile of cranberry in infants and children with recurrent urinary tract infection. An Pediatr (Barc).2015; 82: 397-403.
35. Durham SH, Stamm PL, Eiland LS. Cranberry products for the prophylaxis of urinary tract infections in pediatric patients. Ann Pharmacother 2015; 49(1): 1349-56.
36. Schlager TA, Anderson S, Trudell J, et al. Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr 1999; 135: 698-702.
37. Nishizaki N, Someva T, Hirano D, Fujinaga S, et al. Can cranberry juice be a substitute for cefaclor prophylaxis in children with vesicoureteral reflux? Pediatr Int 2009; 51(3) :433-4.
38. Uberos J, Nogueras-Ocana M, Fernandez-Puentes V, et al. Cranberry syruo vs trimethoprim in the prophylaxis in of recurrent urinary tract infections among children: a controlled trial. Open Access J Clin Trials 2012; 4: 31-38.
39. ESCOP Monographs. Second edition. Supplement 2009. Thieme.
40. Avon J, Monane M, Gurwitz JH, et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 271(10): 751.4.
41. Monografie ESCOP. Le basi scientifiche dei prodotti fitoterapici. 2006 . Planta Medica Edizioni.
42. Turi M, Turi E, Kotjalg S, et al. Influence of aqueous extracts of medical plants on surface hydrophobicity of Escherichia coli strains of different origin. APMIS 1997; 105: 956-62.
43. Head KA. Natural approaches to prevention and trearment of infections of the lower urinary tract. Alter Med Rev 2008 Sep; 13(3): 227-44.
44. Capasso F, Grandolini G, Izzo AA. Fitoterapia. Imiego razionale delle droghe vegetali. 2006. Springer.
45. Sun D, Abraham SN, Beachey EH. Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesion in uropathogenic Escherichia coli. Antimicrob Agents Chemother.1988; 32: 1274-77.